Corynoxeine is primarily studied for its potential neuroprotective and anti-inflammatory effects. It has shown interest in research related to neurological disorders due to its ability to modulate ion channels, particularly calcium and potassium channels, which play key roles in neuronal excitability and signaling. This property suggests possible applications in managing conditions such as epilepsy, neuropathic pain, and other neurodegenerative diseases. Additionally, corynoxeine exhibits antioxidant activity, helping to reduce oxidative stress in brain tissues. This makes it a candidate for investigation in age-related cognitive decline and diseases like Alzheimer's. Some studies also explore its role in improving sleep quality and regulating sleep-wake cycles due to its influence on central nervous system activity. Research is ongoing, and most applications remain in the preclinical stage, based on in vitro and animal models. Its natural origin and low toxicity profile support further development for therapeutic use in neurology and mental health.